Hester Biosciences Ltd Quarterly Results

Gross Sales

81.93

63.22

83.69

82.27

79.26

Excise Duty

0

0

0

0

0

Net Sales

81.93

63.22

83.69

82.27

79.26

Other Operating Income

0

0

0

0

0

Other Income

-5.64

8.78

2.8

2.09

4.63

Total Income

76.29

72

86.49

84.35

83.88

Total Expenditure

62.74

58.16

64.53

64.62

63.33

PBIDT

13.54

13.85

21.96

19.74

20.55

Interest

5.62

-3.81

5.89

5.01

6.94

PBDT

7.92

17.66

16.07

14.73

13.61

Depreciation

4.18

4.29

4.2

4.13

3.74

Minority Interest Before NP

0

0

0

0

0

Tax

4.11

1.65

3.38

3.08

3.92

Deferred Tax

-1.91

0.31

0.1

0.03

-0.45

Reported Profit After Tax

1.54

11.41

8.39

7.49

6.4

Minority Interest After NP

0.25

-0.25

0.19

1.15

1.45

Net Profit after Minority Interest

1.29

11.66

8.2

6.34

4.95

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

1.29

11.66

8.2

6.34

4.95

EPS (Unit Curr.)

1.82

13.41

9.86

8.8

7.52

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.51

8.51

8.51

8.51

8.51

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.52

21.9

26.23

23.99

25.92

PBDTM(%)

9.66

27.93

19.2

17.9

17.17

PATM(%)

1.87

18.04

10.02

9.1

8.07